Friday, March 26, 2021

USFDA

 Source: https://www.moneycontrol.com/news/trends/health-trends/glenmark-pharmaceuticals-gets-usfda-nod-for-generic-antipsychotic-drug-6687361.html

1) Glenmark Pharmaceuticals gets USFDA nod for generic antipsychotic drug

"The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg," Glenmark said in a regulatory filing.

 

Source: https://medicaldialogues.in/news/industry/pharma/glenmark-pharma-gets-usfda-nod-for-diltiazem-hydrochloride-er-capsules-75815

2) Glenmark Pharma gets USFDA nod for Diltiazem Hydrochloride ER Capsules

 Drug Major, Glenmark Pharmaceutical Ltd., announced that the company has received final approval by United States Food &Drug Administration (USFDA) for Diltiazem Hydrochloride Extended Release Capsules USP 60mg., 90mg., and  120mg.

The product is the generic version of Cardizem SR Extended Release Capsules, 60mg., 90mg.,and 120mg.,of Biovail Laboratories Inc.